A Benefit-Risk Review of Systemic Haemostatic Agents: Part 1: In Major Surgery

ISSN： 0114-5916

Source： Drug Safety, Vol.31, Iss.3, 2008-01, pp. : 217-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Benefit-Risk Review of Systemic Haemostatic Agents: Part 2: In Excessive or Heavy Menstrual Bleeding

By Fraser Ian S.

Drug Safety, Vol. 31, Iss. 4, 2008-01 ,pp. : 275-282

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression

By Howland Robert H.

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 709-731

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Class III Antiarrhythmic Agents

By Brendorp B.

Drug Safety, Vol. 25, Iss. 12, 2002-01 ,pp. : 847-865

Adis International

Access to resources Recommend Favorite

A benefit–risk assessment of class III antiarrhythmic agents

By Elming Hanne Brendorp Bente Pehrson Steen Pedersen Ole Dyg Køber Lars Torp-Petersen Christian

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 559-577

Informa Healthcare

Access to resources Recommend Favorite

Psychotic Major Depression: A Benefit-Risk Assessment of Treatment Options

By Tyrka Audrey R. Price Lawrence H. Mello Marcelo F. Mello Andrea F. Carpenter Linda L.

Drug Safety, Vol. 29, Iss. 6, 2006-01 ,pp. : 491-508

Adis International

Access to resources Recommend Favorite